MedPath

Indocyanine green acid form

Generic Name
Indocyanine green acid form
Brand Names
Ic-green
Drug Type
Small Molecule
Chemical Formula
C43H48N2O6S2
CAS Number
28782-33-4
Unique Ingredient Identifier
C4V974V932
Background

Indocyanine Green is a water soluble, tricarbocyanine dye with a peak spectral absorption at 800 nm. The chemical name for Indocyanine Green is 1 H-Benz[e]indolium, 2-[7-[1,3-dihydro-1,1-dimethyl-3-(4-sulfobutyl)-2H-benz[e] indol-2-ylidene]-1,3,5-heptatrienyl]-1,1-dimethyl-3-(4-sulfobutyl)-,hydroxide, inner salt, sodium salt. Indocyanine Green for Injection USP has a pH of approximately 6.5 when reconstituted. Each vial of Indocyanine Green for Injection USP contains 25 mg of Indocyanine Green as a sterile lyophilized powder with no more than 5% sodium iodide.

Indication

For Determining Cardiac Output, Hepatic Function and Liver Blood Flow

For ophthalmic angiography

Use of Indocyanine Green During Primary Repair of Oesophageal Atresia and Distal Tracheo-oesophageal Fistula

Not Applicable
Recruiting
Conditions
Tracheo-Esophageal Fistula with Atresia of Esophagus
Interventions
First Posted Date
2023-02-21
Last Posted Date
2025-03-04
Lead Sponsor
Birmingham Women's and Children's NHS Foundation Trust
Target Recruit Count
20
Registration Number
NCT05735964
Locations
🇬🇧

Birmingham children's hospital, Birmingham, United Kingdom

Use of Indocyanine Green in Acute Cholecystitis

Phase 4
Recruiting
Conditions
Bile Duct Injury
Acute Cholecystitis
Interventions
First Posted Date
2023-02-02
Last Posted Date
2023-09-29
Lead Sponsor
Corporacion Parc Tauli
Target Recruit Count
440
Registration Number
NCT05709548
Locations
🇪🇸

Hospital de Vic, Vic, Barcelona, Spain

🇪🇸

Hospital Universitari Parc Tauli, Sabadell, Barcelona, Spain

Near-infrared Imaging With Indocyanine Green for Detection of Peritoneal Metastases for Gastric Adenocarcinoma.

Phase 2
Terminated
Conditions
Gastric Adenocarcinoma
Peritoneal Carcinomatosis
Peritoneal Metastases
Gastric Cancer
Interventions
First Posted Date
2023-01-18
Last Posted Date
2024-04-02
Lead Sponsor
Laval University
Target Recruit Count
11
Registration Number
NCT05687617
Locations
🇨🇦

CIUSSS de l'Est-de-l'Île-de-Montréal, Montréal, Quebec, Canada

🇨🇦

CHU de Québec, Quebec City, Quebec, Canada

Impact of Sentinel Lymph Node Mapping on Patient Reported Lower Extremity Limb Dysfunction in Stage I Endometrial Cancer

Phase 3
Recruiting
Conditions
Stage I Uterine Corpus Cancer AJCC v8
Interventions
Procedure: Biospecimen Collection
Procedure: Diagnostic Imaging
Procedure: Excisional Biopsy
Procedure: Minimally Invasive Surgery
Procedure: Pelvic Lymphadenectomy
Other: Questionnaire Administration
Procedure: Sentinel Lymph Node Mapping
First Posted Date
2022-12-12
Last Posted Date
2024-07-15
Lead Sponsor
NRG Oncology
Target Recruit Count
428
Registration Number
NCT05646316
Locations
🇺🇸

Fairview Southdale Hospital, Edina, Minnesota, United States

🇺🇸

Northwestern Medicine Cancer Center Warrenville, Warrenville, Illinois, United States

🇺🇸

Parkland Memorial Hospital, Dallas, Texas, United States

and more 38 locations

Indocyanine Green (ICG) Guided Sentinel Lymph Node Mapping for Pediatric Visceral Solid Tumors

Early Phase 1
Recruiting
Conditions
Solid Tumor
Interventions
First Posted Date
2022-12-09
Last Posted Date
2025-01-13
Lead Sponsor
St. Jude Children's Research Hospital
Target Recruit Count
15
Registration Number
NCT05645523
Locations
🇺🇸

St. Jude Children's Research Hospital, Memphis, Tennessee, United States

Artificial Intelligence Analysis of Fluorescence Image to Intraoperatively Detect Metastatic Sentinel Lymph Node.

Recruiting
Conditions
Sentinel Lymph Node
Breast Cancer
Interventions
First Posted Date
2022-11-21
Last Posted Date
2022-11-28
Lead Sponsor
Xiang'an Hospital of Xiamen University
Target Recruit Count
40
Registration Number
NCT05623280
Locations
🇨🇳

Xiamen Key Laboratory of Endocrine-Related Cancer Precision Medicine, Xiamen, Fujian, China

Injection of 99mTc-nanocolloid and ICG to Identify, Retrieve and Qualify TDLN in Early-stage NSCLC

Not Applicable
Completed
Conditions
Early-stage Lung Cancer
Interventions
Radiation: 99mTc-nanocolloid
First Posted Date
2022-09-26
Last Posted Date
2025-02-20
Lead Sponsor
Radboud University Medical Center
Target Recruit Count
72
Registration Number
NCT05555199
Locations
🇳🇱

Radboudumc, Nijmegen, Gelderland, Netherlands

Application of ICG in Lymph Node Dissection During Radical Resection of Rectal Cancer With Preserved Autonomic Nerves Around LCA and IMA

Not Applicable
Completed
Conditions
Indocyanine Green
Interventions
Other: non-ICG
First Posted Date
2022-08-26
Last Posted Date
2022-08-26
Lead Sponsor
The First Hospital of Qinhuangdao
Target Recruit Count
96
Registration Number
NCT05517681
Locations
🇨🇳

The First hosptial of Qinhuangdao, Qinhuangdao, China

Indocyanine Green Test in Bariatric Surgery

Completed
Conditions
Surgery
Obesity, Morbid
Leak, Anastomotic
First Posted Date
2022-07-27
Last Posted Date
2022-07-27
Lead Sponsor
University of Foggia
Target Recruit Count
30
Registration Number
NCT05476159
Locations
🇮🇹

University of Foggia, Foggia, Italy

The Effect of Chemoradiotherapy on Gastric Perfusion in Patients With Gastric Cancer.

Phase 4
Terminated
Conditions
Gastric Cancer
Interventions
First Posted Date
2022-05-02
Last Posted Date
2024-05-02
Lead Sponsor
Rigshospitalet, Denmark
Target Recruit Count
11
Registration Number
NCT05354856
Locations
🇩🇰

Rigshospitalet, Copenhagen, Kbh Ø, Denmark

© Copyright 2025. All Rights Reserved by MedPath